Martha Morrell - 20 Dec 2023 Form 4 Insider Report for NeuroPace Inc (NPCE)

Role
Chief Medical Officer
Signature
/s/ Irina Ridley, Attorney-In-Fact
Issuer symbol
NPCE
Transactions as of
20 Dec 2023
Net transactions value
-$27,695
Form type
4
Filing time
22 Dec 2023, 16:21:59 UTC
Previous filing
07 Dec 2023
Next filing
28 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NPCE Common Stock Sale $27,695 -2,730 -2.2% $10.14 123,429 20 Dec 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.00 to $10.27, inclusive. The reporting person undertakes to provide the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.